
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Eckert & Ziegler Strahlen und Medizintechnik AG
EPS (Diluted)
Eckert & Ziegler Strahlen und Medizintechnik AG
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
EPS (Diluted)
€1
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
![]() |
Carl Zeiss Meditec AG
XETRA:AFX
|
EPS (Diluted)
€1
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Stratec SE
XETRA:SBS
|
EPS (Diluted)
€0
|
CAGR 3-Years
-40%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
|
![]() |
Siemens Healthineers AG
XETRA:SHL
|
EPS (Diluted)
€1
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
![]() |
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
EPS (Diluted)
€6
|
CAGR 3-Years
-20%
|
CAGR 5-Years
18%
|
CAGR 10-Years
1%
|
|
![]() |
Sartorius AG
XETRA:SRT
|
EPS (Diluted)
€1
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
1%
|
Eckert & Ziegler Strahlen und Medizintechnik AG
Glance View
Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. The company is headquartered in Berlin, Berlin and currently employs 866 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

See Also
What is Eckert & Ziegler Strahlen und Medizintechnik AG's EPS (Diluted)?
EPS (Diluted)
1.4
EUR
Based on the financial report for Sep 30, 2024, Eckert & Ziegler Strahlen und Medizintechnik AG's EPS (Diluted) amounts to 1.4 EUR.
What is Eckert & Ziegler Strahlen und Medizintechnik AG's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-1%
Over the last year, the EPS (Diluted) growth was 11%. The average annual EPS (Diluted) growth rates for Eckert & Ziegler Strahlen und Medizintechnik AG have been -4% over the past three years , 6% over the past five years , and -1% over the past ten years .